| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.01 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.01 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.093 | 0.01 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.01 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.083 | 0.01 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.02 |